Skip to content

Investigation of the effectiveness and usefulness of topical gel containing pomegranate husk extract in the healing of diabetic foot ulcers

Investigation of potentially effectiveness of pomegranate husk extract topical gel on wound healing of diabetic foot ulcers: A randomized, parallel controlled phase II clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221031056351N1
Enrollment
40
Registered
2022-11-21
Start date
2022-12-22
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diabetic foot ulcer caused by type 1 diabetes. Condition 2: Diabetic foot ulcer caused by type 2 diabetes. Type 1 diabetes mellitus with peripheral circulatory complications Type 2 diabetes mellitus with peripheral circulatory complications

Interventions

Intervention 1: Control group: The usual wound care from the second day includes washing twice a day with water without betadine along with debridement if needed. Intervention 2: Intervention group: I

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetic patients with ulcers in the lower limbs who have not had more than a 50% reduction in the size of their ulcer during the last month.

Exclusion criteria

Exclusion criteria: Evidence of bone and tendon, an abscess with local erythema and tenderness at the wound site, osteomyelitis, malignancy, use of anti-inflammatory drugs and growth factors in the last 2 weeks and radiotherapy in the last three months, and lack of consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
Duration of complete wound healing (initial). Timepoint: at different times of 7, 14, 21 and 30 days. Method of measurement: Based on the diabetic foot ulcer assessment checklist.

Secondary

MeasureTime frame
Wound area before intervention and after intervention on days 7, 14, 21, and 30 (secondary). Timepoint: at different times of 7, 14, 21 and 30 days. Method of measurement: Based on the diabetic foot ulcer assessment checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Mohammadimotlagh

Kermanshah University of Medical Sciences

hamidreza.mohammadimotlagh@kums.ac.ir+98 83 3427 6473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026